SS
CLYM

Steve Schonfeld’s Climb Bio CLYM Stock Holding History

Steve Schonfeld’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
+126,138
New +$1.3M 0.01% 1176
2025
Q2 		– Sell
-442,661
Closed -$540K – 2655
2025
Q1 		$540K Sell
442,661
-22,439
-5% -$36.4K ﹤0.01% 1551
2024
Q4 		$837K Buy
+465,100
New +$1.68M ﹤0.01% 1193

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Steve Schonfeld's CLYM Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Climb Bio (CLYM) in Q2 2026: 126,138 shares worth $1.64M. The stake represents 0.01% of the portfolio and ranks #1176 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in CLYM as recently as Q1 2025.

Steve Schonfeld first reported a position in CLYM in Q4 2024 and has held it in 3 quarters since. 108 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Steve Schonfeld held 126,138 shares of Climb Bio worth $1.64M as of Q2 2026.
  • Climb Bio was a new Steve Schonfeld position in Q2 2026.
  • Climb Bio made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1176 holding.
  • Steve Schonfeld first reported a position in Climb Bio in Q4 2024 and has held it in 3 quarters since.
  • 108 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.